Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance. - Yoon JH; Lee JH; Yang DH; Cheong JW; Byun JM; Yoo KH; Woo J; Kim YM; Lee S (Annals of hematology, 2026)